Compare BCG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCG | HBIO |
|---|---|---|
| Founded | 2016 | 1901 |
| Country | United States | United States |
| Employees | 150 | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4M | 26.5M |
| IPO Year | N/A | 2000 |
| Metric | BCG | HBIO |
|---|---|---|
| Price | $1.54 | $6.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 19.7K | 15.9K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | N/A | $4.77 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | $56.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.36 | $0.38 |
| 52 Week High | $3.44 | $7.50 |
| Indicator | BCG | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 57.83 |
| Support Level | $1.50 | $6.05 |
| Resistance Level | $1.68 | $6.69 |
| Average True Range (ATR) | 0.08 | 0.28 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 20.01 | 86.87 |
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.